Premium
OK‐432 Therapy for Recalcitrant Warts
Author(s) -
Inui Shigeki,
Asada Hideo,
WatayaKaneda Mari,
Miyamoto Tomoko,
Itami Satoshi,
Yoshikawa Kunihiko
Publication year - 1997
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.1997.tb02794.x
Subject(s) - medicine , cryotherapy , malaise , surgery , subcutaneous injection , dermatology
Twelve patients with warts recalcitrant to various treatments, including cryotherapy, were treated with OK‐432 injection therapy. Six patients received only subcutaneous injection, three received only intralesional injection, and the other three received both subcutaneous and intralesional injections. Complete clearing of the warts occurred in nine (75%) of 12 patients, while the other three patients were not cured. Grouping the patients by the method of injection, the success rate of subcutaneous injection was 5/9 (55.6%), and that of intralesional injection was 4/6 (66.7%). Although five patients complained of mild fever and malaise, these side effects gradually disappeared during the repeated injections. OK‐432 injection is considered as a hopeful therapy for recalcitrant warts.